# The Elderly ACS II Trial

Study · id `cardio:ct-nct01777503` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01777503](<https://clinicaltrials.gov/study/NCT01777503>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01777503

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1457 participants.

## Technical summary

Registry record NCT01777503. Randomized; single masking; primary purpose treatment. Start 2012-11 (actual); primary completion 2017-01-25 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 1457 participants (enrolled count; ClinicalTrials.gov record NCT01777503, source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)
- Started: 2012-11 (actual) (ClinicalTrials.gov record NCT01777503, source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)
- Primary completion: 2017-01-25 (actual) (ClinicalTrials.gov record NCT01777503, source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)
- Completion: 2017-12-19 (actual) (ClinicalTrials.gov record NCT01777503, source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)
- Countries: Italy (ClinicalTrials.gov record NCT01777503, source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01777503-2025-06-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Elderly ACS II Trial
- Condition: Acute Coronary Syndrome
- Condition: Coronary Arteriosclerosis
- Condition: Myocardial Ischemia
- Condition: Cardiovascular Diseases
- Intervention (Drug): prasugrel
- Intervention (Drug): Clopidogrel
- Lead sponsor: Azienda USL Reggio Emilia - IRCCS
- Lead sponsor class: OTHER\_GOV
- Collaborator: ANMCO Italian Association of Hospital Cardiologist
- Collaborator class: UNKNOWN
- Collaborator: Italian Society of Invasive Cardiology
- Collaborator class: OTHER
- Collaborator: A. Manzoni Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry intervention name matches this record: Prasugrel (`cardio:prasugrel`)
- Registry intervention name matches this record: Clopidogrel (`cardio:clopidogrel`)
- Registry intervention is a member of this class by a sourced record link: P2Y12 inhibitors (drug class) (`cardio:p2y12-inhibitors`)
- Registry lists this organization as a collaborator: Italian Society of Invasive Cardiology (`cardio:org-italian-society-of-invasive-cardiology`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization (`cardio:pubmed-29459361`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Time Course of Ischemic and Bleeding Burden in Elderly Patients With Acute Coronary Syndromes Randomized to Low-Dose Prasugrel or Clopidogrel (`cardio:pubmed-30636561`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 673792e81257659ed1451024184795ed14aa478383a49190be728ada06258033
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
